Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a new site revision label (v3.4.2). An older government funding maintenance notice has been removed; no study content or data is changed.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now shows a site-wide funding-status notice and updates the version to v3.4.1 (replacing v3.4.0), with no changes to study-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary and Revision: v3.4.0. Removed the older QC label variant 'Last Update Submitted that met QC Criteria' (lowercase), 'No FEAR Act data', and the revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedConsolidated Locations section now lists all study sites by state (CA, FL, IL, KS, MD, MT, NE, NJ, NY, TX, VA). Per-state Location headings were removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedThe page shows Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.